Literature DB >> 18295491

Synthesis and anti-cancer activity of benzothiazole containing phthalimide on human carcinoma cell lines.

Stanton Hon Lung Kok1, Roberto Gambari, Chung Hin Chui, Marcus Chun Wah Yuen, Eva Lin, Raymond Siu Ming Wong, Fung Yi Lau, Gregory Yin Ming Cheng, Wing Sze Lam, Sau Hing Chan, Kim Hung Lam, Chor Hing Cheng, Paul Bo Shan Lai, Michael Wing Yiu Yu, Filly Cheung, Johnny Cheuk On Tang, Albert Sun Chi Chan.   

Abstract

Phthalic anhydride is a highly toxic substance, facing, however, the problem of hydrolysis. In fact, it is rapidly hydrolyzed in aqueous medium, generating phthalic acid as the final product, which is almost harmless to viable cells. Here we describe the 'one pot' condensation reaction for the synthesis of phthalic imide derivative (benzothiazole containing phthalimide), exhibiting in vitro cytotoxic potential on human cancer cell lines. We further demonstrated that both caspase-dependent and -independent pathways are involved in our novel benzothiazole containing phthalimide induced apoptosis on cancer cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18295491     DOI: 10.1016/j.bmc.2008.02.005

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  15 in total

1.  A novel inhibitor of Rho GDP-dissociation inhibitor α improves the therapeutic efficacy of paclitaxel in Lewis lung carcinoma.

Authors:  Xing Chen Peng; Xu Xia Chen; Y U Zhang; Hai Jun Wang; You Feng
Journal:  Biomed Rep       Date:  2015-05-27

2.  Synthesis, docking and anticancer activity of azo-linked hybrids of 1,3,4-thia-/oxadiazoles with cyclic imides.

Authors:  Priyanka Bhatt; Manoj Kumar; Anjali Jha
Journal:  Mol Divers       Date:  2018-06-08       Impact factor: 2.943

3.  New Succinimides with Potent Anticancer Activity: Synthesis, Activation of Stress Signaling Pathways and Characterization of Apoptosis in Leukemia and Cervical Cancer Cells.

Authors:  Marcin Cieślak; Mariola Napiórkowska; Julia Kaźmierczak-Barańska; Karolina Królewska-Golińska; Anna Hawrył; Iwona Wybrańska; Barbara Nawrot
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

4.  Phthalimide analogs as probable 15-lipoxygenase-1 inhibitors: synthesis, biological evaluation and docking studies.

Authors:  Alireza Aliabadi; Ahmad Mohammadi-Farani; Zeinab Hosseinzadeh; Hamid Nadri; Alireza Moradi; Farahnaz Ahmadi
Journal:  Daru       Date:  2015-07-22       Impact factor: 3.117

5.  SKLB-163, a new benzothiazole-2-thiol derivative, exhibits potent anticancer activity by affecting RhoGDI/JNK-1 signaling pathway.

Authors:  X Peng; G Xie; Z Wang; H Lin; T Zhou; P Xiang; Y Jiang; S Yang; Y Wei; L Yu; Y Zhao
Journal:  Cell Death Dis       Date:  2014-03-27       Impact factor: 8.469

6.  Antitumor and antimetastatic activities of a novel benzothiazole-2-thiol derivative in a murine model of breast cancer.

Authors:  XiaoLin Hu; Sen Li; Yan He; Ping Ai; Shaoyong Wu; Yonglin Su; Xiaolin Li; Lei Cai; Xingchen Peng
Journal:  Oncotarget       Date:  2017-02-14

7.  Design and Synthesis of 4-flurophthalimides as potential anticonvulsant agents.

Authors:  Maryam Iman; Sina Fakhari; Mohammad Jahanpanah; Nima Naderi; Asghar Davood
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

8.  Inhibition of tumor growth and angiogenesis by 2-(4-aminophenyl) benzothiazole in orthotopicglioma C6 rat model.

Authors:  De-Qiang Lei; Xing-Li Deng; Hong-Yang Zhao; Fang-Cheng Zhang; Ru-En Liu
Journal:  Saudi J Biol Sci       Date:  2017-04-13       Impact factor: 4.219

9.  5-Chloro-2-phenyl-1,3-benzothia-zole.

Authors:  Sammer Yousuf; Shazia Shah; Nida Ambreen; Khalid M Khan; Shakil Ahmed
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-08-31

10.  Design, Synthesis and Anticancer Screening of Novel Benzothiazole-Piperazine-1,2,3-Triazole Hybrids.

Authors:  Mohamed R Aouad; Moataz A Soliman; Muath O Alharbi; Sanaa K Bardaweel; Pramod K Sahu; Adeeb A Ali; Mouslim Messali; Nadjet Rezki; Yaseen A Al-Soud
Journal:  Molecules       Date:  2018-10-27       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.